KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Notes Payables (2019 - 2021)

BioNTech SE's Notes Payables history spans 3 years, with the latest figure at $148.6 million for Q4 2021.

  • For Q4 2021, Notes Payables rose 1269.62% year-over-year to $148.6 million; the TTM value through Dec 2021 reached $148.6 million, up 1269.62%, while the annual FY2021 figure was $148.6 million, 1269.62% up from the prior year.
  • Notes Payables for Q4 2021 was $148.6 million at BioNTech SE, up from $10.8 million in the prior quarter.
  • Across five years, Notes Payables topped out at $148.6 million in Q4 2021 and bottomed at $5.9 million in Q4 2019.
  • The 3-year median for Notes Payables is $10.8 million (2020), against an average of $55.1 million.
  • The largest annual shift saw Notes Payables soared 84.7% in 2020 before it surged 1269.62% in 2021.
  • A 3-year view of Notes Payables shows it stood at $5.9 million in 2019, then skyrocketed by 84.7% to $10.8 million in 2020, then soared by 1269.62% to $148.6 million in 2021.
  • Per Business Quant, the three most recent readings for BNTX's Notes Payables are $148.6 million (Q4 2021), $10.8 million (Q4 2020), and $5.9 million (Q4 2019).